Matches in Wikidata for { <http://www.wikidata.org/entity/Q96644460> ?p ?o ?g. }
- Q96644460 description "2020 nî lūn-bûn" @default.
- Q96644460 description "2020年の論文" @default.
- Q96644460 description "2020年学术文章" @default.
- Q96644460 description "2020年学术文章" @default.
- Q96644460 description "2020年学术文章" @default.
- Q96644460 description "2020年学术文章" @default.
- Q96644460 description "2020年学术文章" @default.
- Q96644460 description "2020年学术文章" @default.
- Q96644460 description "2020年學術文章" @default.
- Q96644460 description "2020年學術文章" @default.
- Q96644460 description "2020年學術文章" @default.
- Q96644460 description "2020年學術文章" @default.
- Q96644460 description "2020年學術文章" @default.
- Q96644460 description "2020년 논문" @default.
- Q96644460 description "article científic" @default.
- Q96644460 description "article scientific" @default.
- Q96644460 description "article scientifique" @default.
- Q96644460 description "articol științific" @default.
- Q96644460 description "articolo scientifico" @default.
- Q96644460 description "artigo científico" @default.
- Q96644460 description "artigo científico" @default.
- Q96644460 description "artigo científico" @default.
- Q96644460 description "artikel ilmiah" @default.
- Q96644460 description "artikull shkencor" @default.
- Q96644460 description "artikulong pang-agham" @default.
- Q96644460 description "artykuł naukowy" @default.
- Q96644460 description "artículo científico publicado en 2020" @default.
- Q96644460 description "artículu científicu" @default.
- Q96644460 description "bilimsel makale" @default.
- Q96644460 description "bài báo khoa học" @default.
- Q96644460 description "naučni članak" @default.
- Q96644460 description "scienca artikolo" @default.
- Q96644460 description "scientific article published on 23 June 2020" @default.
- Q96644460 description "scientific article published on 23 June 2020" @default.
- Q96644460 description "scientific article published on 23 June 2020" @default.
- Q96644460 description "teaduslik artikkel" @default.
- Q96644460 description "tieteellinen artikkeli" @default.
- Q96644460 description "tudományos cikk" @default.
- Q96644460 description "vedecký článok" @default.
- Q96644460 description "vetenskaplig artikel" @default.
- Q96644460 description "videnskabelig artikel udgivet 23. juni 2020" @default.
- Q96644460 description "vitenskapelig artikkel" @default.
- Q96644460 description "vitskapeleg artikkel" @default.
- Q96644460 description "vědecký článek" @default.
- Q96644460 description "wetenschappelijk artikel" @default.
- Q96644460 description "wissenschaftlicher Artikel" @default.
- Q96644460 description "επιστημονικό άρθρο" @default.
- Q96644460 description "мақолаи илмӣ" @default.
- Q96644460 description "наукова стаття, опублікована в червні 2020" @default.
- Q96644460 description "научна статия" @default.
- Q96644460 description "научная статья" @default.
- Q96644460 description "научни чланак" @default.
- Q96644460 description "научни чланак" @default.
- Q96644460 description "գիտական հոդված հրատարակված 2020 թվականի հունիսի 23-ին" @default.
- Q96644460 description "מאמר מדעי" @default.
- Q96644460 description "مقالة علمية نشرت في 23 يونيو 2020" @default.
- Q96644460 description "২৩ জুন ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q96644460 description "บทความทางวิทยาศาสตร์" @default.
- Q96644460 description "სამეცნიერო სტატია" @default.
- Q96644460 name "Phase III study to evaluate patient's preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)" @default.
- Q96644460 name "Phase III study to evaluate patient's preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)" @default.
- Q96644460 type Item @default.
- Q96644460 label "Phase III study to evaluate patient's preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)" @default.
- Q96644460 label "Phase III study to evaluate patient's preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)" @default.
- Q96644460 prefLabel "Phase III study to evaluate patient's preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)" @default.
- Q96644460 prefLabel "Phase III study to evaluate patient's preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)" @default.
- Q96644460 P1433 Q96644460-37CCA424-BE70-421B-BCD2-8D5D756A62C8 @default.
- Q96644460 P1476 Q96644460-ABC0F8DA-6FBD-42F6-830D-F2AD907142B6 @default.
- Q96644460 P2093 Q96644460-0ACA17CB-4202-43BA-B9DA-0C19FAEB9D70 @default.
- Q96644460 P2093 Q96644460-13C2D3B1-F675-4A7A-AB92-9DDA4DF40148 @default.
- Q96644460 P2093 Q96644460-175C56FC-DE31-4F05-BAF7-E27A213602F4 @default.
- Q96644460 P2093 Q96644460-194A4CB4-0802-44C8-B47F-63C5FAF7EF96 @default.
- Q96644460 P2093 Q96644460-25C93010-076C-4739-8BA9-B5EA202B6D03 @default.
- Q96644460 P2093 Q96644460-2EBB8B32-401D-4AEC-B3C1-291CBC79B287 @default.
- Q96644460 P2093 Q96644460-310AA32B-7BB4-4AB4-8EAA-9C746734267B @default.
- Q96644460 P2093 Q96644460-32CE08E6-EACF-4E9F-9D91-0FE4AE8D6B2C @default.
- Q96644460 P2093 Q96644460-335F8F82-59AE-41F0-A95F-4BA213D0A610 @default.
- Q96644460 P2093 Q96644460-3732F48C-9299-4B94-A91A-04A0722AC34D @default.
- Q96644460 P2093 Q96644460-54EC4A46-F4ED-4EAE-86B7-2748C6BF966D @default.
- Q96644460 P2093 Q96644460-754C8280-0B4C-46BC-BAA4-C5B401E5D556 @default.
- Q96644460 P2093 Q96644460-91DF6875-9920-4A20-8FAA-0115A15A13A1 @default.
- Q96644460 P2093 Q96644460-95927DBD-87C4-4A74-986F-F7D5699E9F88 @default.
- Q96644460 P2093 Q96644460-9D3A42DB-729D-4B38-8AE6-37AA1331F910 @default.
- Q96644460 P2093 Q96644460-A31AA489-447F-413D-984D-D537999D2976 @default.
- Q96644460 P2093 Q96644460-C7765780-FD5D-4E0E-A048-F0C0F8182040 @default.
- Q96644460 P2093 Q96644460-D8FE9137-967A-45AB-BE32-93D4C6A979F4 @default.
- Q96644460 P2093 Q96644460-FA618848-1C13-440C-B943-0685D76E4AC7 @default.
- Q96644460 P304 Q96644460-48D8F019-A53E-450A-8E24-519A08C2A52F @default.
- Q96644460 P31 Q96644460-755844AC-6ACD-4A7A-8704-2662DA3708FC @default.
- Q96644460 P356 Q96644460-DEBE8EC4-826F-4DA8-BC47-D03C90A86022 @default.
- Q96644460 P50 Q96644460-44247721-D8A1-4658-B4BB-67ECE226C6B8 @default.
- Q96644460 P577 Q96644460-4F3417D2-C19C-433B-AAD6-5845A01B58D2 @default.
- Q96644460 P698 Q96644460-DB2D13FD-E0E9-47F6-807C-A3B5491E01B2 @default.
- Q96644460 P921 Q96644460-0A447A7E-A316-4AD8-92E2-788E67246E3F @default.
- Q96644460 P921 Q96644460-9C6D72FD-8D7A-41A1-82E0-A9BE809FF479 @default.
- Q96644460 P356 ECC.13253 @default.
- Q96644460 P698 32578279 @default.
- Q96644460 P1433 Q5412710 @default.
- Q96644460 P1476 "Phase III study to evaluate patient's preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)" @default.
- Q96644460 P2093 "Alvaro Montaño" @default.